| 000 | 01399 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515211445.0 | ||
| 264 | 0 | _c20100706 | |
| 008 | 201007s 0 0 rus d | ||
| 022 | _a1561-9125 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnisimov, S V | |
| 245 | 0 | 0 |
_a[Cell therapy for Parkinson's disease: IV. Risks and future trends]. _h[electronic resource] |
| 260 |
_bAdvances in gerontology = Uspekhi gerontologii _c2009 |
||
| 300 |
_a418-39 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEmbryonic Stem Cells |
| 650 | 0 | 4 | _aEthics |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHaplorhini |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMesenchymal Stem Cells |
| 650 | 0 | 4 | _aPapio |
| 650 | 0 | 4 |
_aParkinson Disease _ximmunology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aStem Cell Transplantation _xtrends |
| 650 | 0 | 4 |
_aStem Cells _xcytology |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aWorld Health Organization |
| 650 | 0 | 4 | _aZoonoses |
| 773 | 0 |
_tAdvances in gerontology = Uspekhi gerontologii _gvol. 22 _gno. 3 _gp. 418-39 |
|
| 999 |
_c19577356 _d19577356 |
||